Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Asthma Attack: later-stage trial registry
3 of 5 indexed Asthma Attack trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Asthma Attack: 5 US clinical trials tracked, 3 recruiting.
Asthma Attack is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Areteia Therapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition asthma-attack
OPEN 3 | RECR 60% | LATE 2 | EARLY 1 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)
Asthma Attack lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Asthma Attack on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Asthma Attack is recruiting above its size-band peers.
3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Asthma Attack research.
Areteia Therapeutics accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Asthma Attack enrolment sits around 100 participants.
Median target enrolment is 100 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Asthma Attack splits between interventional and observational designs.
3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Individualizing Treatment for Asthma in Primary Care (Full Study)
DARTNet Institute
NCT07052942
Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
University of Oklahoma
NCT06137040
Wearable Electronic Breath Sound Sensing Device
Emory University
NCT06734793
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
Areteia Therapeutics
NCT05748600
User-Friendly Spirometer and Mobile App for Self-Management and Home Monitoring of Asthma Patients
University of California, San Francisco
NCT03642418
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Asthma Attack records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Asthma Attack trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Asthma Attack page
5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Asthma Attack trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Areteia Therapeutics sponsors the most Asthma Attack trials on record, review their full trial history before evaluating a specific study. See Areteia Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Asthma Attack condition card totals 5 registered trials; most-linked intervention Dexpramipexole Dihydrochloride; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.